1. Facial Angiofibroma Severity Index (FASI): reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis‐associated facial angiofibroma. (1st December 2014) Authors: Salido‐Vallejo, R.; Ruano, J.; Garnacho‐Saucedo, G.; Godoy‐Gijón, E.; Llorca, D.; Gómez‐Fernández, C.; Moreno‐Giménez, J. C. Journal: Clinical and experimental dermatology Issue: Volume 39:Number 8(2014) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Facial Angiofibroma Severity Index (FASI): reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis‐associated facial angiofibroma. (20th August 2014) Authors: Salido‐Vallejo, R.; Ruano, J.; Garnacho‐Saucedo, G.; Godoy‐Gijón, E.; Llorca, D.; Gómez‐Fernández, C.; Moreno‐Giménez, J. C. Journal: Clinical and experimental dermatology Issue: Volume 39:Number 8(2014) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗